-
Mashup Score: 1Vaccines and immunotherapy in hematological malignancies - 4 year(s) ago
David E. Avigan, MD, Beth Israel Deaconess Medical Center and Dana-Farber/Harvard Cancer Center, Boston, MA, discusses the use of vaccines…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Point-of-care CAR T-cells - 4 year(s) ago
Marcos de Lima, MD, UH Cleveland Medical Center, Cleveland, OH, discusses the significance of point-of-care CAR T-cell therapies. This interview…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Brentuximab vedotin + nivolumab in lymphoma - 4 year(s) ago
David J. Straus, MD, Memorial Sloan-Kettering Cancer Center, New York, NY, discusses updates from a study evaluating brentuximab vedotin, an…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Next steps in multiple myeloma - 4 year(s) ago
Sagar Lonial, MD, FACP, Winship Cancer Institute of Emory University, Atlanta, GA, discusses next steps in the treatment and management…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Updates from the German CLL Study Group - 4 year(s) ago
Michael Hallek, MD, University Hospital of Cologne, Cologne, Germany, updates us on the latest news from the German CLL Study…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Management of adult T-ALL - 4 year(s) ago
Nitin Jain, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, outlines the management of patients with T-cell…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Magrolimab in TP53 mutated AML and MDS - 4 year(s) ago
David Sallman, MD, of H. Lee Moffitt Cancer Center, Tampa, FL, outlines the use of magrolimab in TP53 mutated acute…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Treating highly relapsed/refractory CLL - 4 year(s) ago
Michael Hallek, MD, of the University Hospital of Cologne, Cologne, Germany, outlines treatment options for relapsed/refractory patients with chronic lymphocytic…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Next questions in AML - 4 year(s) ago
Amer Zeidan, MBBS, Yale University and Yale Cancer Center, New Haven, CT, explores the next questions in acute myeloid leukemia…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Gilteritinib in R/R AML - 4 year(s) ago
Naval Daver, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, outlines the use of gilteritinib, a tyrosine…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
VIDEO: Vaccines and immunotherapy in hematological malignancies with David Avigan of @BIDMChealth and @harvardmed: https://t.co/QlXf0Q8i8e @SocietyofHemOnc #SOHO2020 #OncoAlert @OncoAlert #ImmunoOnc